Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
DYU37E
|
|||
| Drug Name |
EDP-1503
|
|||
| Drug Type |
Live biotherapeutic product
|
|||
| Indication | Melanoma [ICD-11: 2C30; ICD-9: 172] | Phase 2 | [1] | |
| Company |
Evelo Biosciences
|
|||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | ClinicalTrials.gov (NCT03595683) Pembrolizumab and EDP1503 in Advanced Melanoma. U.S. National Institutes of Health. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.